188 related articles for article (PubMed ID: 32808348)
1. Deficiency of pseudogene UPAT leads to hepatocellular carcinoma progression and forms a positive feedback loop with ZEB1.
Xiang L; Huang X; Wang S; Ou H; Chen Z; Hu Z; Huang Y; Li X; Yuan Y; Yang D
Cancer Sci; 2020 Nov; 111(11):4102-4117. PubMed ID: 32808348
[TBL] [Abstract][Full Text] [Related]
2. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway.
Li SP; Xu HX; Yu Y; He JD; Wang Z; Xu YJ; Wang CY; Zhang HM; Zhang RX; Zhang JJ; Yao Z; Shen ZY
Oncotarget; 2016 Jul; 7(27):42431-42446. PubMed ID: 27285757
[TBL] [Abstract][Full Text] [Related]
4. GINS1 promotes ZEB1-mediated epithelial-mesenchymal transition and tumor metastasis via β-catenin signaling in hepatocellular carcinoma.
Liang J; Yao N; Deng B; Li J; Jiang Y; Liu T; Hu Y; Cao M; Hong J
J Cell Physiol; 2024 May; 239(5):e31237. PubMed ID: 38468464
[TBL] [Abstract][Full Text] [Related]
5. IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-κB signaling pathway.
Guo Q; Yu DY; Yang ZF; Liu DY; Cao HQ; Liao XW
Dig Liver Dis; 2020 May; 52(5):573-581. PubMed ID: 31818638
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG3 Promotes Hepatocellular Tumorigenesis by Targeting miR-326.
Zhao Q; Wu C; Wang J; Li X; Fan Y; Gao S; Wang K
Tohoku J Exp Med; 2019 Sep; 249(1):43-56. PubMed ID: 31548493
[TBL] [Abstract][Full Text] [Related]
7. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
Qiu G; Lin Y; Zhang H; Wu D
Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
[TBL] [Abstract][Full Text] [Related]
8. ZEB1 promotes tumorigenesis and metastasis in hepatocellular carcinoma by regulating the expression of vimentin.
Qin Y; Yu J; Zhang M; Qin F; Lan X
Mol Med Rep; 2019 Mar; 19(3):2297-2306. PubMed ID: 30664206
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
[TBL] [Abstract][Full Text] [Related]
10. Super-Enhancer-Associated Long Noncoding RNA HCCL5 Is Activated by ZEB1 and Promotes the Malignancy of Hepatocellular Carcinoma.
Peng L; Jiang B; Yuan X; Qiu Y; Peng J; Huang Y; Zhang C; Zhang Y; Lin Z; Li J; Yao W; Deng W; Zhang Y; Meng M; Pan X; Li C; Yin D; Bi X; Li G; Lin DC
Cancer Res; 2019 Feb; 79(3):572-584. PubMed ID: 30482773
[TBL] [Abstract][Full Text] [Related]
11. A long non-coding RNA lncRNA-PE promotes invasion and epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-200a/b-ZEB1 pathway.
Shen Y; Liu S; Yuan H; Ying X; Fu H; Zheng X
Tumour Biol; 2017 May; 39(5):1010428317705756. PubMed ID: 28488544
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor DCAF15 inhibits epithelial-mesenchymal transition by targeting ZEB1 for proteasomal degradation in hepatocellular carcinoma.
Dong X; Han Y; Zhang E; Wang Y; Zhang P; Wang C; Zhong L; Li Q
Aging (Albany NY); 2021 Apr; 13(7):10603-10618. PubMed ID: 33833131
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of long noncoding RNA linc-ITGB1 suppresses migration, invasion of hepatocellular carcinoma via regulating ZEB1.
Yu WW; Wang K; Liao GJ
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5089-5095. PubMed ID: 29228420
[TBL] [Abstract][Full Text] [Related]
15. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
16. The miR-200b-ZEB1 circuit regulates diverse stemness of human hepatocellular carcinoma.
Tsai SC; Lin CC; Shih TC; Tseng RJ; Yu MC; Lin YJ; Hsieh SY
Mol Carcinog; 2017 Sep; 56(9):2035-2047. PubMed ID: 28383782
[TBL] [Abstract][Full Text] [Related]
17. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma.
Li X; Yuan J; Song C; Lei Y; Xu J; Zhang G; Wang W; Song G
Cell Death Differ; 2021 Aug; 28(8):2315-2332. PubMed ID: 33649471
[TBL] [Abstract][Full Text] [Related]
18. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
[TBL] [Abstract][Full Text] [Related]
19. ELF3 promotes epithelial-mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma.
Zheng L; Xu M; Xu J; Wu K; Fang Q; Liang Y; Zhou S; Cen D; Ji L; Han W; Cai X
Cell Death Dis; 2018 Mar; 9(3):387. PubMed ID: 29523781
[TBL] [Abstract][Full Text] [Related]
20. The Conserved LncRNA DIO3OS Restricts Hepatocellular Carcinoma Stemness by Interfering with NONO-Mediated Nuclear Export of ZEB1 mRNA.
Hou YR; Diao LT; Hu YX; Zhang QQ; Lv G; Tao S; Xu WY; Xie SJ; Zhang Q; Xiao ZD
Adv Sci (Weinh); 2023 Aug; 10(23):e2301983. PubMed ID: 37271897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
